[ad_1]
The Bahrain News Agency said: “The National Authority for the Regulation of Professions and Health Services today approved the emergency use of the vaccine manufactured by Pfizer and Biontech against Coronavirus (Covid-19), making the I reign as the second country in the world to authorize the use of this vaccine. “
The agency indicated that the vaccine will be available for “groups at greatest risk of contracting complications from Coronavirus, including the elderly, people with chronic diseases and other groups determined by the Ministry of Health with the aim of providing anti-virus vaccines. “.
This was based on the study conducted by the National Authority for the Regulation of Professions and Health Services and the Vaccination Committee of the Ministry of Health in the light of information provided by Pfizer on the results it monitored for the vaccine in terms of safety and efficacy.
Last November, Bahrain approved the use of the Sinopharm vaccine to immunize frontline workers.
A few days ago the British authorities announced the granting of the necessary licenses for the Pfizer-Biontech vaccine, so that anyone over the age of 16 could receive the doses, except for pregnant women due to the lack of data so far on the its impact on fetuses.
And last November, Pfizer announced that its Corona vaccine, which it is developing with Biontech, is over 90% effective.
In a press conference, Ben Osborne, head of Pfizer’s UK subsidiary, said: “We do not actually disclose any details on any aspect of this agreement, particularly the terms of liability.”
When Pfizer was asked when full data from a clinical trial of the vaccine would be released, it said work is underway in this context.
.
[ad_2]
Source link
